All In Biotech

Drug Trial Radar · NCT04125836

A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

A Phase 3, Open-label, Single-arm, Multi-center Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With Acromegaly

Last checked: Nov 19, 2026Latest source record: Dec 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

135

Actual

Start

Oct 10, 2019

Primary completion

Apr 24, 2025

Study completion Apr 24, 2025

Sponsor

Lead sponsor
Camurus ABIndustry
Sponsor type
Industry
First posted
Oct 14, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is to assess the long-term safety and efficacy of CAM2029 in patients with acromegaly. Patients will be administered CAM2029 subcutaneously once monthly during 12 months. Patients fulfilling trial NCT04076462 will be offered to continue with open-label treatment week 24-52 in this trial. Patients completing the main part of the trial will be offered 52 weeks continued open-label treatment in an extension part.

Conditions

  • Acromegaly

Interventions

  • CAM2029 (octreotide subcutaneous depot)Drug

    Octreotide subcutaneous depot for monthly injections in acromegaly patients

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Characterization of adverse events (AEs)Time frame: Week 0-52

Locations

68 sites in 11 countries. Site status is shown where the registry gives one.

  • UCLA Department of Medicine Division of Endocrinology

    Los Angeles, California

  • Stanford University Medical Center

    Palo Alto, California

  • Prufen Clinical Research LLC

    Miami, Florida

  • University of Michigan

    Ann Arbor, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University in St. Louis, School of Medicine

    St Louis, Missouri

  • Palm Research Center

    Las Vegas, Nevada

  • Columbia University Medical Center

    New York, New York

  • University of Cincinnati

    Cincinnati, Ohio

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • Allegheny Endocrinology Associates

    Pittsburgh, Pennsylvania

  • Research Institute of Dallas

    Dallas, Texas

  • Universitätsklinikum Essen

    Essen, Germany

  • Universitätsklinikum Frankfurt, Medizinische Klinik 1, Schwerpunkt Endokrinologie, Diabetologie, Ernährungsmedizin

    Frankfurt, Germany

  • Universitätsklinikum Freiburg

    Freiburg im Breisgau, Germany

  • Universitätsklinikum Leipzig

    Leipzig, Germany

  • LMU Clinic of University of Munich, Medical Clinic and Polyclinic IV

    Munich, Germany

  • Medicover Neuroendokrinologie

    Munich, Germany

  • Medicover Oldenburg MVZ

    Oldenburg, Germany

  • General Hospital of Athens "Laiko", Endocrinology University Clinic

    Athens, Greece

  • Aretaeio University Hospital Endocrinology Department, Faculty of Diabetes and Metabolism

    Athens, Greece

  • General Hospital of Thessaloniki "Ippokratio"

    Thessaloniki, Greece

  • Military Health Center, 2nd Department of Internal Medicine

    Budapest, Hungary

  • SZTE ÁOK I.sz. Belgyógyászati Klinika

    Szeged, Hungary

  • IRCCS Policlinico San Martino

    Genova, Italy

  • Azienda Universitaria "Federico II"

    Naples, Italy

  • Azienda Ospedaliera Padova, Department of Internal medicine

    Padova, Italy

  • Policlinic Gemelli University Hospital IRCCS, Department of Endocrinology

    Roma, Italy

  • AOUI Verona, Policlinic of GB Rossi

    Verona, Italy

  • Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie

    Krakow, Poland

  • Centrum Nowoczesnych Terapii "Dobry Lekarz"

    Krakow, Poland

  • Amicare Sp. z o.o. Sp. K.

    Lodz, Poland

  • Piekarskie Centrum Medyczne, Szpital Miejski

    Piekary Śląskie, Poland

  • Interregional Clinical Diagnostic Center

    Kazan', Russia

  • "Atlas" Medical Center

    Moscow, Russia

  • Sechenov Moscow First State Medical University

    Moscow, Russia

  • Vladimirsky Moscow Regional Research Clinical Institute

    Moscow, Russia

  • Novosibirsk State Regional Clinical Hospital

    Novosibirsk, Russia

  • Interregional Clinical Diagnostic Center

    Ryazan, Russia

  • Saratov Regional Clinic Hospital

    Saratov, Russia

Showing 40 of 68 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.